• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 016 Publication Date: 11/03/2006 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 7-4: CLSI / NCCLS GP14-A 1996, Labeling of Home-Use In Vitro Testing Products; Approved Guideline. (InVitro Diagnostics)

Date of Standard: 1996. 
Addresses of Standards Organizations:
  Clinical Laboratory Standards Institute (CLSI)
  950 West Valley Road
  Suite 2500
  Wayne, PA 19087
 
  National Committee for Clinical Laboratory Standards (NCCLS)
  950 West Valley Road
  Suite 2500
  Wayne, PA 19087
 
CDRH Offices and Divisions Associated with Recognized Standards:
(1)OFFICE OF DEVICE EVALUATION (ODE)
(2)OFFICE OF COMPLIANCE (OC)
Devices Affected:
Home Use IVD's
Processes Affected:
Manufacturing/Devices Evaluation (510(k), PMA, PDP, IDE)
Type of Standard:
 National, Horizontal
Extent of Recognition:
Complete standard
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§862.1115 Azo-Dyes, Colorimetric, Bilirubin & Its Conjugates (Urinary, Non-Quant.) Class 1 JJB
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1155 Agglutination Method, Human Chorionic Gonadotropin Class 2 JHJ
§862.1155 Kit, Test, Pregnancy, Hcg, Over The Counter Class 2 LCX
§862.1155 Visual, Pregnancy Hcg, Prescription Use Class 2 JHI
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1170 Mercuric Nitrate And Diphenyl Carbazone (Titrimetric), Chloride Class 2 CHK
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1175 Enzymatic Esterase--Oxidase, Cholesterol Class 1 CHH
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1340 Method, Enzymatic, Glucose (Urinary, Non-Quantitative) Class 2 JIL
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1345 Glucose Oxidase, Glucose Class 2 CGA
§862.1345 Hexokinase, Glucose Class 2 CFR
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1435 Nitroprusside, Ketones (Urinary, Non-Quant.) Class 1 JIN
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1485 Radioimmunoassay, Luteinizing Hormone Class 1 CEP
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1510 Diazo (Colorimetric), Nitrite (Urinary, Non-Quant) Class 1 JMT
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1550 Dye-Indicator, Ph (Urinary, Non-Quant.) Class 1 CEN
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1645 Indicator Method, Protein Or Albumin (Urinary, Non-Quant.) Class 1 JIR
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.1785 Diazonium Colorimetry, Urobilinogen (Urinary, Non-Quant.) Class 1 CDM
 
Regulation
Number
Device Name Device
Class
Product
Code
§862.2300 Colorimeter, Photometer, Spectrophotometer For Clinical Use Class 1 JJQ
 
Regulation
Number
Device Name Device
Class
Product
Code
§864.6550 Blood, Occult, Colorimetric, In Urine Class 2 JIO
§864.6550 Reagent, Occult Blood Class 2 KHE
 
Regulation
Number
Device Name Device
Class
Product
Code
§864.7470 Assay, Glycosylated Hemoglobin Class 2 LCP
 
Regulation
Number
Device Name Device
Class
Product
Code
§866.2900 Device, Specimen Collection Class 1 LIO
 
Relevant Guidance:
Review Criteria for Assessment of Over-The-Counter Human Chorionic Gonadotropin (HCG) In Vitro Diagnostic Devices. Guidance for 510(k)s on Cholesterol Tests for Clinical Laboratory, Physicians Office Laboratories, and Home Use. Points to Consider for Approval of Home Drugs of Abuse Test Kits. Assessing the Safety/Effectiveness of Home-Use In Vitro Diagnostic Devices
FDA Technical Contact:
  Arleen Pinkos
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room 5618
  Silver Spring MD 20993
  301/796-6152
  Email: arleen.pinkos@fda.hhs.gov
-
-